Australians now reassured they will have access to essential medicines in their next emergency

Friday 25 March 2022

 

The Pharmaceutical Society of Australia (PSA) strongly supports today’s announcement that continued dispensing arrangements will become permanent later this year.

 

This morning, the Minister for Health and Ageing, the Hon Greg Hunt, announced that from 1 July 2021, continued dispensing arrangements, currently set to expire on 30 June, will become permanent across Australia.

 

PSA National President, A/Prof Chris Freeman, applauded the development.

 

“From the 1^st of July this year, a permanent measure will come into effect which ensures that Australians can continue to access essential medicines during times of an emergency. We applaud the Government making these common-sense arrangements permanent.

 

“Whether it be a pandemic, flood, bushfire, or a family tragedy, this provides Australians with confidence they can access their essential medicines when they may not be able to access their prescriptions or a doctor.

 

“Being able to access PBS subsidy for emergency supply of medicines is vital to ensuring patients are not hit with out-of-pocket costs during vulnerable times.

 

“These emergency measures have clearly been successful throughout the pandemic. Over an 18-month period, between January 2020 and the end of June 2021, more than 600,000 vital medicines were accessed under these provisions.

 

“After a tumultuous few years of natural disasters and five temporary extensions to the measures, this was the logical and sensible step to take – particularly given no major problems have been identified.

 

“PSA’s standards and guidelines have proved critical to helping the profession navigate the expanded provisions throughout the pandemic.

 

“Now it’s up to state and territory governments to enable this by ensuring that regulations and barriers currently precluding these arrangements are removed,” A/Prof Freeman said.

 

PSA will continue to work closely with all governments to progress and implement nationally consistent emergency supply provisions.

 

Media contact: PSA media 0424 777 463

 

Support for pharmacists

• Guidelines for the Continued Dispensing of eligible prescribed medicines by pharmacists
• COVID-19 Regulatory Changes: Expanded Continued Dispensing

Tasmanian pharmacists now eligible to vaccinate children against COVID-19

Friday 25th March 2022

 

The Pharmaceutical Society of Australia’s (PSA) Tasmanian Branch has welcomed the announcement that pharmacist immunisers in Tasmania are now eligible to protect the state’s children against COVID-19.

 

Today, Premier Gutwein confirmed changes to allow the provision of COVID-19 vaccinations for children aged 5-11 through local pharmacies.

 

PSA Tasmania Branch President, David Peachey, said immunity in Tasmania’s young people is the missing link at the moment and pharmacists can play a key role in protecting this important population.

 

“This is welcomed news for Tasmania’s pharmacist immunisers, who will now be able to opt-in to provide COVID-19 vaccinations to this paediatric cohort.

 

“We are delighted that the state will now be brought in line with the rest of the nation, improving access to vaccination for families residing in regional parts of the state.

 

“It is imperative that all Tasmanian children can access COVID-19 vaccinations from pharmacists, Australia’s most accessible healthcare workforce, in order to keep themselves, their families and the community safe.

 

“Vaccination is the best way to ensure that these susceptible populations and their families are protected against the virus, and soon, they’ll have the convenient option of protecting themselves through local pharmacies.

 

“Our pharmacists are trained and experienced in vaccinating younger age groups against other vaccine-preventable diseases and are now on standby to protect them against COVID-19.

 

“Authorised immunisers must have successfully completed the mandatory vaccine training provided by the Department of Health, including all the relevant vaccine-specific modules for vaccines available through the pharmacy program,” Mr Peachey said.

 

PSA continues to work closely with the TGA and ATAGI to ensure pharmacists are equipped with the most up-to-date advice regarding vaccine safety and effectiveness.

 

Media contact: PSA media 0424 777 463

 

PSA welcomes Government’s commitment to improve medicine safety in Aged Care

Friday 25 March 2022

 

The Pharmaceutical Society of Australia (PSA) welcomes the Government’s commitment to provide funding of $345.7 million to improve medicine safety for older Australians by embedding pharmacists in residential aged care facilities.

 

This morning, the Minister for Health and Ageing, the Hon Greg Hunt, announced that from 1 January 2023, pharmacists will play an even greater role in dispensing medicines within Australia’s residential aged care facilities.

 

PSA National President, A/Prof Chris Freeman, was in attendance when the announcement was made.

 

“Today’s announcement from Minister Hunt has been long-awaited. This is a win for those residents who will now have greater access to medicines experts, our pharmacists, and I have no doubt that this sentiment will be shared by the aged care sector.

 

“PSA has been advocating for funding to improve medicine safety in residential aged care facilities since 2018, following the establishment of the Royal Commission into Aged Care – and now, almost four years later, the Government has taken action.

 

“The Royal Commission into Aged Care detailed well-known issues like the overuse of psychotropic medicines, and since then, troubling data on medication misadventure has continued to emerge.

 

“Since the Royal Commission was established, PSA has been working closely with all governments to implement recommendations outlined in our Medicine safety: aged care report from 2020, and it is incredibly pleasing to see that our advice has been heeded.

 

“With more than 19,000 Australians in residential aged care prescribed antipsychotics with no indication, the level of chemical restraint must be addressed. We also know that the more medicines someone is prescribed, the more likely it is to cause harm.

 

“The evidence is clear – pharmacists need to be an embedded part of the aged care equation if medication misadventure is to be minimised and rectified.

 

“As the custodians and experts of medication safety, embedding pharmacists in aged care is the obvious solution to address the longstanding issues of polypharmacy and chemical restraint in aged care facilities. We are delighted that the Government will now invest in our pharmacist workforce to improve the quality of care for aged care residents.

 

“Over the next four years, this $345.7 million contribution to supporting pharmacists embedded in aged care will make a significant difference to protecting and improving the quality of life for our aged care residents. Consultation on the most suitable model will occur over the next six months.

 

“It is crucial that aged care service providers are allowed the flexibility to determine how they secure pharmacist services. Some facilities may choose to contract pharmacists through community pharmacies, some may choose to employ a pharmacist directly, or via a third party.

 

“It can’t be a one size fits all approach as every facility is different. Therefore, all of these options must be accommodated.

 

“We look forward to working with the Minister and the Department of Health on the implementation.” A/Prof Freeman said.

 

Get involved

PSA is here to support Australian pharmacists who are interested in working within the aged care sector. For more information on becoming a Residential Aged Care Pharmacist, please visit this link. PSA also offers the Residential Aged Care Pharmacist: Foundation Training Program, available here.

 

Background

PSA’s Medicine safety: aged care report found that:

 

• Over 95% of people living in aged care facilities have at least one problem with their medicines detected at the time of a medicines review; most have three problems
• 50% of people with dementia are taking medicines with anticholinergic properties, which can worsen confusion and other symptoms of dementia.
• One fifth of people living in aged care are on antipsychotics; more than half use the medicine for too long.

 

The Report from the Royal Commission in to Aged Care Quality and Safety recommended that “the Australian Government immediately improve access to quality medication management reviews for people receiving aged care by:

1. allowing and funding pharmacists from 1 January 2022 to conduct reviews on entry to residential care and annually thereafter, or more often if there has been a significant change to the person receiving care’s condition or medication regimen;
2. amending the criteria for eligibility for residential medication management reviews to include people in residential respite care and transition care;
3. monitoring quality and consistency of medication management reviews.”

 

The Royal Commission detailed well known issues in medicine management – notably the use of restrictive practices which could not be justified in 90% of cases, and overuse of sedating medicines.

 

PSA has suggested that a flexible practice model is needed to give aged care providers and residents the best access to pharmacist-delivered care, and accreditation of pharmacists entering aged care to perform medication reviews must remain mandatory to support consistent, high quality care.

 

 

Media contact: PSA media 0424 777 463

Closing the Gap on health inequality

Thursday 17^th March 2022

 

Health equality is a fundamental human right and it is critical that Australia meets this standard for all Aboriginal and Torres Strait Islander peoples.

 

The Pharmaceutical Society of Australia (PSA) believes that Australia’s healthcare system must strive to better meet the needs of Aboriginal and Torres Strait Islander peoples to protect and support health, wellbeing, culture and Country.

 

PSA National President, A/Prof Chris Freeman, said that progress is being made in improving Aboriginal and Torres Strait Islander health, but there is still a long way to go.

 

“PSA believes that health equality as a fundamental right for all, and as today is National Close the Gap Day, I reiterate that we must continue to take steps toward achieving health equality for First Nations Peoples. I thank those pharmacists supporting and working towards quality use of medicines with Aboriginal and Torres Strait Islander communities.

 

“PSA calls on the government to consider expanding the Closing the Gap Pharmaceutical Benefits Scheme Co-payment Program to include PBS medicines supplied under special supply arrangements established under Section 100 of the National Health Act 1953.

 

“As clinicians, it is critical that we continue to practise cultural humility and strive to challenge unconscious bias in order to move toward culturally safe and responsive models of care.

 

“Models of care must align with the six domains of the Cultural Respect Framework 2016-2026 for Aboriginal and Torres Strait Islander Health, with the overarching aim to improve the access and responsiveness of the health system in Australia.

 

“PSA respects the principle of self-determination and acknowledges that Aboriginal and Torres Strait Islander people know what is best for themselves, their families and communities.

 

“We recognise that Aboriginal and Torres Strait Islander peoples’ connection to family, community, culture and Country is critical to wellbeing and positive self-identity.

 

“PSA respects the need for Aboriginal-led transformation, and recognises the resilience, strengths and leadership of Aboriginal and Torres Strait Islander peoples, communities and organisations.

 

“When Aboriginal and Torres Strait Islander people are involved in the design of the services they need, success is far more likely to be achieved.

 

“Sadly, only a small proportion, roughly 0.3%, of registered pharmacists in Australia identify as Aboriginal or Torres Strait Islander people. Through promotion of initiatives like the Aboriginal and Torres Strait Islander Pharmacy Scholarship Scheme, the Aboriginal and Torres Strait Islander Pharmacy Assistant Traineeship Scheme and creating opportunities to showcase Aboriginal and Torres Strait Islander pharmacists at events such as PSA’s annual conference, PSA is dedicated to increasing this degree of representation.

 

“As the lead organisation for the Integrating Pharmacists within Aboriginal Community Controlled Health Services (IPAC) project, PSA also continues to advocate for models of care which further enables pharmacists to support the health and wellbeing of Aboriginal and Torres Strait Islander peoples.

 

“PSA is proud to have our Reconciliation Action Plan endorsed by Reconciliation Australia, a framework which signifies our commitment to driving reconciliation throughout the organisation. This strategy builds further on current reconciliation initiatives by means of awareness and action,” A/Prof Freeman said.

 

 

Media contact: PSA media 0424 777 463